Rodler, S.; Eismann, L.; Schlenker, B.; Casuscelli, J.; Brinkmann, I.; Sendelhofert, A.; Waidelich, R.; Buchner, A.; Stief, C.; Schulz, G.B.;
et al. Expression of Nectin-4 in Variant Histologies of Bladder Cancer and Its Prognostic Value—Need for Biomarker Testing in High-Risk Patients? Cancers 2022, 14, 4411.
https://doi.org/10.3390/cancers14184411
AMA Style
Rodler S, Eismann L, Schlenker B, Casuscelli J, Brinkmann I, Sendelhofert A, Waidelich R, Buchner A, Stief C, Schulz GB,
et al. Expression of Nectin-4 in Variant Histologies of Bladder Cancer and Its Prognostic Value—Need for Biomarker Testing in High-Risk Patients? Cancers. 2022; 14(18):4411.
https://doi.org/10.3390/cancers14184411
Chicago/Turabian Style
Rodler, Severin, Lennert Eismann, Boris Schlenker, Jozefina Casuscelli, Isabel Brinkmann, Andrea Sendelhofert, Raphaela Waidelich, Alexander Buchner, Christian Stief, Gerald Bastian Schulz,
and et al. 2022. "Expression of Nectin-4 in Variant Histologies of Bladder Cancer and Its Prognostic Value—Need for Biomarker Testing in High-Risk Patients?" Cancers 14, no. 18: 4411.
https://doi.org/10.3390/cancers14184411
APA Style
Rodler, S., Eismann, L., Schlenker, B., Casuscelli, J., Brinkmann, I., Sendelhofert, A., Waidelich, R., Buchner, A., Stief, C., Schulz, G. B., & Ledderose, S.
(2022). Expression of Nectin-4 in Variant Histologies of Bladder Cancer and Its Prognostic Value—Need for Biomarker Testing in High-Risk Patients? Cancers, 14(18), 4411.
https://doi.org/10.3390/cancers14184411
